| [1] |
Mebazaa A, Yilmaz MB, Levy P, et al. Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine--short version[J]. Eur Heart J, 2015, 36(30):1958–1966.
|
| [2] |
Levy B, Bastien O, Benjelid K, et al. Experts' recommendations for the management of adult patients with cardiogenic shock[J]. Ann Intensive Care, 2015, 5(1):52.
|
| [3] |
Peura JL, Colvin-Adams M, Francis GS, et al. Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association[J]. Circulation, 2012, 126(22):2648–2667.
|
| [4] |
Rihal CS, Naidu SS, Givertz MM, et al. 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention[J]. J Am Coll Cardiol, 2015, 65(19):e7–e26.
|
| [5] |
Papaioannou TG, Stefanadis C. Basic principles of the intraaortic balloon pump and mechanisms affecting its performance[J]. Asaio j, 2005, 51(3):296–300.
|
| [6] |
Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[J]. Circulation, 2011, 124(23):e574–651.
|
| [7] |
Perera D, Stables R, Thomas M, et al. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial[J]. Jama, 2010, 304(8):867–874.
|
| [8] |
Perera D, Stables R, Clayton T, et al. Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention[J]. Circulation, 2013, 127(2):207–212.
|
| [9] |
Patel MR, Smalling RW, Thiele H, et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial[J]. Jama, 2011, 306(12):1329–1337.
|
| [10] |
Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery)[J]. J Am Coll Cardiol, 2004, 44(5):e213–310.
|
| [11] |
O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol, 2013, 61(4):e78–140.
|
| [12] |
中华医学会心血管病学分会. 急性ST段抬高型心肌梗死诊断和治疗指南[J]. 中华心血管病杂志, 2015, 43(5):380–393.
|
| [13] |
Thiele H, Schuler G, Neumann FJ, et al. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock Ⅱ (IABP-SHOCK Ⅱ) trial[J]. Am Heart J, 2012, 163(6):938–945.
|
| [14] |
Negi SI, Kar B, Gregoric I, et al. Supporting the failing myocardium: is intra-aortic balloon pump enough? The IABP-SHOCK Ⅱ trial[J]. Expert Rev Cardiovasc Ther, 2013, 11(2):147–149.
|
| [15] |
Khashan MY, Pinsky MR. Does intra-aortic balloon support for myocardial infarction with cardiogenic shock improve outcome[J]? Crit Care, 2013, 17(2):307.
|
| [16] |
Thiele H, Zeymer U, Neumann FJ, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCKⅡ): final 12 month results of a randomised, open-label trial[J]. Lancet, 2013, 382(9905):1638–1645.
|
| [17] |
Romeo F, Acconcia MC, Sergi D, et al. The outcome of intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock according to the type of revascularization: a comprehensive meta-analysis[J]. Am Heart J, 2013, 165(5):679–692.
|
| [18] |
Unverzagt S, Buerke M, de Waha A, et al. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock[J]. Cochrane Database Syst Rev, 2015, 3:Cd007398.
|
| [19] |
Extracorporeal Life Support Organization (ELSO)：Guidelines for Adult Cardiac Failure 2013 [EB/OL].
URL
|
| [20] |
Thiagarajan RR, Brogan TV, Scheurer MA, et al. Extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in adults[J]. Ann Thorac Surg, 2009, 87(3):778–785.
|
| [21] |
Nichol G, Karmy-Jones R, Salerno C, et al. Systematic review of percutaneous cardiopulmonary bypass for cardiac arrest or cardiogenic shock states[J]. Resuscitation, 2006, 70(3):381–394.
|
| [22] |
Takayama H, Truby L, Koekort M, et al. Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era[J]. J Heart Lung Transplant, 2013, 32(1):106–111.
|
| [23] |
Cheng R, Hachamovitch R, Kittleson M, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1, 866 adult patients[J]. Ann Thorac Surg, 2014, 97(2):610–616.
|
| [24] |
Xie A, Phan K, Tsai YC, et al. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest: a meta-analysis[J]. J Cardiothorac Vasc Anesth, 2015, 29(3):637–645.
|
| [25] |
Alli OO, Singh IM, Holmes DR, et al. Percutaneous left ventricular assist device with TandemHeart for high-risk percutaneous coronary intervention: the Mayo Clinic experience[J]. Catheter Cardiovasc Interv, 2012, 80(5):728–734.
|
| [26] |
Kar B, Gregoric ID, Basra SS, et al. The percutaneous ventricular assist device in severe refractory cardiogenic shock[J]. J Am Coll Cardiol, 2011, 57(6):688–696.
|
| [27] |
Burkhoff D CH, Brunckhorst C, et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock[J]. Am Heart J, 2006, 152(3):469.e461–468.
|
| [28] |
Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction[J]. J Am Coll Cardiol, 2008, 52(19):1584–1588.
|
| [29] |
Maini B, Naidu SS, Mulukutla S, et al. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry[J]. Catheter Cardiovasc Interv, 2012, 80(5):717–725.
|
| [30] |
O'Neill WW, Kleiman NS, Moses J, et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT Ⅱ study[J]. Circulation, 2012, 126(14):1717–1727.
|
| [31] |
Doll N, Kiaii B, Borger M, et al. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock[J]. Ann Thorac Surg, 2004, 77(1):151–157.
|